0ND5 vs AMBU-B: Side-by-Side Comparison
Compare H Lundbeck A/S (0ND5) and Ambu A/S (AMBU-B) side by side: valuation, financials, growth and model signals on Bullrun.
| Metric | 0ND5 | AMBU-B |
|---|---|---|
| Company | H Lundbeck A/S | Ambu A/S |
| Country / Exchange | Denmark · LSE | Denmark · CO |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Medical Devices |
| Market cap | — | DKK 16.06B |
| P/E ratio | — | 34.1 |
| Dividend yield | — | 0.67% |
| Valuation model | — | fairly valued |
| Revenue (latest FY) | DKK 24.63B | DKK 6.04B |
| Revenue growth YoY | +11.9% | +12.0% |
| Net income | DKK 3.19B | DKK 609.00M |
| Gross margin | 82.7% | 60.2% |
| Diluted EPS | 3.22 | 2.28 |